CA2122592A1 - System for Delivering an Active Substance for Sustained Release - Google Patents

System for Delivering an Active Substance for Sustained Release

Info

Publication number
CA2122592A1
CA2122592A1 CA 2122592 CA2122592A CA2122592A1 CA 2122592 A1 CA2122592 A1 CA 2122592A1 CA 2122592 CA2122592 CA 2122592 CA 2122592 A CA2122592 A CA 2122592A CA 2122592 A1 CA2122592 A1 CA 2122592A1
Authority
CA
Canada
Prior art keywords
active substance
delivering
sustained release
coating
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2122592
Other languages
French (fr)
Other versions
CA2122592C (en
Inventor
Terrence Bruce Mazer
Glenn Alan Meyer
Shie-Ming Hwang
Edrick Leonard Candler Jr.
Lonnie Richard Drayer
Andre Daab-Krzykowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Terrence Bruce Mazer
Glenn Alan Meyer
Shie-Ming Hwang
Edrick Leonard Candler Jr.
Lonnie Richard Drayer
Andre Daab-Krzykowski
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terrence Bruce Mazer, Glenn Alan Meyer, Shie-Ming Hwang, Edrick Leonard Candler Jr., Lonnie Richard Drayer, Andre Daab-Krzykowski, Abbott Laboratories filed Critical Terrence Bruce Mazer
Publication of CA2122592A1 publication Critical patent/CA2122592A1/en
Application granted granted Critical
Publication of CA2122592C publication Critical patent/CA2122592C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin

Abstract

A system for delivering an active substance has sustained release of the active substance in the intestinal tract. This delivery system is especially useful for an active substance such as a .beta.-lactam antibiotic which preferably has minimal exposure to the ac-idic environment of the stomach. Particles comprise an active ingredient disposed in a core which has at least one coating of a prolamine and one coating of an enteric compound thereon. The particles may be very small and suspended in a liquid medium.
CA002122592A 1991-12-31 1992-12-21 System for delivering an active substance for sustained release Expired - Fee Related CA2122592C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US816,412 1991-12-31
US07/816,412 US5160742A (en) 1991-12-31 1991-12-31 System for delivering an active substance for sustained release
PCT/US1992/011160 WO1993012772A1 (en) 1991-12-31 1992-12-21 System for delivering an active substance for sustained release

Publications (2)

Publication Number Publication Date
CA2122592A1 true CA2122592A1 (en) 1993-07-08
CA2122592C CA2122592C (en) 1997-08-05

Family

ID=25220519

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002122592A Expired - Fee Related CA2122592C (en) 1991-12-31 1992-12-21 System for delivering an active substance for sustained release

Country Status (7)

Country Link
US (1) US5160742A (en)
EP (1) EP0619733B1 (en)
AU (1) AU3418993A (en)
CA (1) CA2122592C (en)
DE (1) DE69232007T2 (en)
MX (1) MX9207263A (en)
WO (1) WO1993012772A1 (en)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681585A (en) 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
SG52402A1 (en) * 1992-12-22 1998-09-28 Univ Cincinnati Oral administration of immunologically active biomolecules and other therapeutic proteins
US5645880A (en) * 1993-07-08 1997-07-08 Mcardle; Blaise Protein-polysaccharide complex composition and method of use
FR2710649A1 (en) * 1993-09-30 1995-04-07 Germinal Sarl Prolamine-based polymeric film, process for its preparation and its applications
EE03305B1 (en) * 1994-07-08 2000-12-15 Astra Aktiebolag Multiparticulate tableted dosage form I
US5728403A (en) * 1994-10-05 1998-03-17 The Board Of Regents Of The University Of Nebraska Coating technology for taste masking orally administered bitter drugs
US5871751A (en) * 1994-10-12 1999-02-16 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Renibacterium salmoninarum vaccine and method for its preparation
US6277092B1 (en) 1995-01-13 2001-08-21 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531681A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Apparatus for altering composition of nutritional product during enteral tube feeding
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
SE9600071D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE512835C2 (en) * 1996-01-08 2000-05-22 Astrazeneca Ab Dosage form containing a plurality of units all containing acid labile H + K + ATPase inhibitors
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600072D0 (en) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
FR2752732B1 (en) * 1996-08-28 1998-11-20 Pf Medicament EXTENDED RELEASE GALENIC FORM OF MILNACIPRAN
AU8293498A (en) 1997-07-02 1999-01-25 Euro-Celtique S.A. Stabilized sustained release tramadol formulations
AU738512B2 (en) 1997-10-03 2001-09-20 Lavipharm Laboratories, Inc. A prolamine-plant polar lipid composition, its method of preparation and applications thereof
AU1150799A (en) * 1997-10-10 1999-05-03 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6251432B1 (en) * 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US6395198B1 (en) 1999-10-01 2002-05-28 Mcardle Biaise Anti-caking and anti-dusting composition and corresponding methods
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
CA2519211A1 (en) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited Release control compositions
KR20120080241A (en) 2003-06-20 2012-07-16 뉴트리니아 리미티드 Bioactive compounds protection method and compositions containing the same
US20050147663A1 (en) * 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
RU2375048C2 (en) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Pharmacological composition with swelling coating
US20070122480A1 (en) * 2003-09-29 2007-05-31 Cj Corporation Sustained release formulations
US20050095300A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
US20050226929A1 (en) * 2004-04-12 2005-10-13 Jianbo Xie Controlled release opioid analgesic formulation
DE102004026706A1 (en) * 2004-05-28 2005-12-15 Merck Patent Gmbh Oral dosage form containing probiotic bacteria
FR2872044B1 (en) * 2004-06-28 2007-06-29 Flamel Technologies Sa PHARMACEUTICAL FORMULATION BASED ON ANTIBIOTICS IN THE MICROCAPSULAR FORM
AU2005305192A1 (en) * 2004-11-04 2006-05-18 Merck Frosst Canada Ltd Process for granulating particles
US7303766B2 (en) * 2005-02-03 2007-12-04 J.M. Huber Corporation Coated/treated metal silicate absorbent particles
MX2008003213A (en) * 2005-09-09 2008-03-18 Kellog Co Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same.
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
PL1993559T3 (en) 2006-02-03 2017-01-31 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
LT2679228T (en) 2006-06-21 2018-05-10 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
US8765178B2 (en) 2006-07-19 2014-07-01 Watson Laboratories, Inc. Controlled release formulations and associated methods
JP2010525080A (en) 2007-04-25 2010-07-22 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー Safe and effective treatment and prevention method for secondary hyperparathyroidism in chronic kidney disease
KR101495578B1 (en) * 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 Method of treating vitamin d insufficiency and deficiency
WO2008134512A1 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
JP5647516B2 (en) * 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド Methods and compounds for vitamin D therapy
WO2009041945A1 (en) * 2007-09-28 2009-04-02 Capricorn Pharma Inc. Coated compositions and methods for preparing same
TWI391150B (en) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd Enteric sustained-release coated core and pharmaceutical dosage form and manufacturing method thereof
ES2954932T3 (en) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Useful methods, compositions, uses and kits for vitamin D deficiency and related disorders
US9504274B2 (en) * 2009-01-27 2016-11-29 Frito-Lay North America, Inc. Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
US9968564B2 (en) 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
CA2820751A1 (en) * 2010-12-10 2012-06-14 The Governors Of The University Of Alberta Barley protein microcapsules
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
CR20170085A (en) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D
ES2919874T3 (en) * 2014-09-24 2022-07-28 Vital Beverages Global Inc Compositions and methods for selective delivery to the gastrointestinal tract
CA2936741C (en) 2014-10-31 2018-11-06 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
RS64623B1 (en) 2016-03-24 2023-10-31 Elgan Pharma Ltd Use of insulin for promoting gastric emptying
JP7032322B2 (en) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド Vitamin D treatment
US10849938B2 (en) 2017-09-13 2020-12-01 ZBiotics Company Gene expression system for probiotic microorganisms
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
NO98434A (en) * 1959-04-30
US3117027A (en) * 1960-01-08 1964-01-07 Wisconsin Alumni Res Found Apparatus for coating particles in a fluidized bed
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
US3196827A (en) * 1962-11-19 1965-07-27 Wisconsin Alumni Res Found Apparatus for the encapsulation of discrete particles
US3253944A (en) * 1964-01-13 1966-05-31 Wisconsin Alumni Res Found Particle coating process
US3241520A (en) * 1964-10-19 1966-03-22 Wisconsin Alumni Res Found Particle coating apparatus
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
US3802896A (en) * 1972-05-15 1974-04-09 Nutrilite Products Color concentrated base dispersion used in tablet film coating
US3939259A (en) * 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
US4323312A (en) * 1977-08-26 1982-04-06 Werner Glatt Fluidized bed apparatus
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments
US4384004A (en) * 1981-06-02 1983-05-17 Warner-Lambert Company Encapsulated APM and method of preparation
US4704284A (en) * 1982-08-12 1987-11-03 Pfizer Inc. Long-acting matrix tablet formulations
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS59220175A (en) * 1983-05-28 1984-12-11 Furointo Sangyo Kk Coating of health food
US4876094A (en) * 1984-01-13 1989-10-24 Battelle Development Corporation Controlled release liquid dosage formulation
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS60221078A (en) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd Granular product of useful microorganism powder and its preparation
JPS61141862A (en) * 1984-12-17 1986-06-28 Furointo Sangyo Kk Edible slow-releasing granule
BR8506634A (en) * 1984-12-20 1986-09-09 Rhone Poulenc Sante COMPOSITES FOR COATING FOOD ADDITIVES INTENDED FOR RUMINANTS AND GRANULATES IN THE FORM OF MICROCAPSULES SO COATED
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
JPS62201823A (en) * 1986-02-28 1987-09-05 Freunt Ind Co Ltd Material containing beneficial enterobacterium and production thereof
CH671155A5 (en) * 1986-08-18 1989-08-15 Clinical Technologies Ass
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
JPS63151353A (en) * 1986-12-15 1988-06-23 Oogawara Kakoki Kk Preparation of wax-coated microcapsule
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2624351B1 (en) * 1987-12-15 1991-11-22 Rhone Poulenc Sante ENZYMATICALLY DEGRADABLE COMPOSITIONS FOR COATING FOOD ADDITIVES FOR RUMINANTS
FI101344B (en) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co The method comprises preparing a preparation from which a pharmaceutically active substance is released in a controlled manner
IL92344A0 (en) * 1989-01-04 1990-07-26 Gist Brocades Nv Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
US4976968A (en) * 1989-02-24 1990-12-11 Clinical Technologies Associates, Inc. Anhydrous delivery systems for pharmacological agents
US4983402A (en) * 1989-02-24 1991-01-08 Clinical Technologies Associates, Inc. Orally administerable ANF
DE3911903A1 (en) * 1989-04-12 1990-10-18 Bosch Gmbh Robert Displacement pump for liq. - uses C=shaped pumping member performing orbiting motion inside C=shaped chamber
US5077053A (en) * 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same
IT1246382B (en) * 1990-04-17 1994-11-18 Eurand Int METHOD FOR THE TARGETED AND CONTROLLED DELIVERY OF DRUGS IN THE INTESTINE AND PARTICULARLY IN THE COLON
CA2085342A1 (en) * 1990-06-14 1991-12-15 Milton R. Kaplan Stable aqueous drug suspensions

Also Published As

Publication number Publication date
MX9207263A (en) 1993-06-01
DE69232007D1 (en) 2001-09-20
WO1993012772A1 (en) 1993-07-08
EP0619733B1 (en) 2001-08-16
AU3418993A (en) 1993-07-28
DE69232007T2 (en) 2002-04-18
CA2122592C (en) 1997-08-05
EP0619733A1 (en) 1994-10-19
EP0619733A4 (en) 1995-06-07
US5160742A (en) 1992-11-03

Similar Documents

Publication Publication Date Title
CA2122592A1 (en) System for Delivering an Active Substance for Sustained Release
AU6770490A (en) Solid pharmaceutical compositions containing cimetidine
CA2110185A1 (en) Encapsulated Bioactive Substances
IL92225A0 (en) Delivery systems containing aminopolysaccharide derivatives for the delivery of pharmaceutically active materials
EP0750494A4 (en) Hydrophobic drug delivery systems
AU652135B2 (en) Two-part device for the controlled delivery of an active ingredient
CA2290531A1 (en) Pharmaceutical formulation of omeprazole
AU635021B2 (en) Extended release pharmaceutical formulations
DE69213800D1 (en) Oral gastric juice-stable drugs with controlled release of active ingredients containing bile acids and their salts
CA2065809A1 (en) Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
CA2099855A1 (en) Antigastritis Agent
ZA912793B (en) Pharmaceutical formulations
AU9130691A (en) Stable suspension formulations for controlled delivery of pharmaceutical compounds
AU5806998A (en) Processes for spray drying solutions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
AU7115691A (en) Improved method for the preparation of sweetening agent delivery systems containing polyvinyl acetate
SI0868912T1 (en) Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
AU4132993A (en) Preparation of gastric acid-resistant microspheres containing buffered-bile acids
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
AU3573793A (en) 3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidine-4-ones pharmaceutical compositions containing the same and the preparation thereof
CA2181693A1 (en) Device for administration of beneficial materials to ruminants
CA2376894A1 (en) Pharmaceutical composition comprising a protein and an ectoine
AU3408493A (en) Process for the preparation of dialkyl 2,3-pyridinedicarboxylate and derivatives thereof from an alpha,beta-unsaturated oxime and an aminobutenedioate
HUT59319A (en) Pharmaceutical compositions with controlled release of active ingredient and process for producing same
ZA891718B (en) Orally administered system for the controller release of active substances
AU1432292A (en) Drug delivery composition and method of using the same

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed